A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. - Berlato C; Khan MN; Schioppa T; Thompson R; Maniati E; Montfort A; Jangani M; Canosa M; Kulbe H; Hagemann UB; Duncan AR; Fletcher L; et al. (The Journal of clinical investigation, 2017)